Randomised phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer (OCTOVA): a study protocol

INTRODUCTION: Patients relapsing within 12 months of platinum-based chemotherapy usually have a poorer response to subsequent treatments. To date, extensive research into the mechanism of resistance to platinum agents in the treatment of ovarian cancer has not resulted in improved responses or longe...

全面介紹

Na minha lista:
書目詳細資料
發表在:BMJ Open
Main Authors: Mansouri, Anita, McGregor, Naomi, Dunn, Rachel, Dobbie, Sam, Holmes, Jane, Collins, Linda, Nicum, Shibani
格式: Artigo
語言:Inglês
出版: BMJ Publishing Group 2021
主題:
Oncology
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7813404/
https://ncbi.nlm.nih.gov/pubmed/33452192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2020-041463
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍